International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies - Summary - MDSpire

International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies

  • By

  • Anne Brédart

  • Jean-Luc Kop

  • Omar Shamieh

  • Louis Fox

  • Waleed Alrjoub

  • Thierry Conroy

  • Nazim Serdar Turhal

  • I. Juan Arraras

  • Renée Bultijnck

  • Amélie Harle

  • Mieke Van Hemelrijck

  • Eleonora Pinto

  • Eric J. U. Roth

  • Georgios Ioannidis

  • Anna Costantini

  • Tara Chalk

  • Teresa Young

  • Gudrun Rohde

  • Hiroto Ishiki

  • Yuichiro Kikawa

  • Heike Schmidt

  • Vassilios Vassiliou

  • Stephanie Shayler

  • Frédéric Marchal

  • Anota Amélie

  • Jens Lehmann

  • November 26, 2025

  • 0 min

Share

Objective:

To validate the EORTC PATSAT-C33 and OUT-PATSAT7 questionnaires for assessing patient satisfaction in cancer care, emphasizing the importance of cultural diversity across different settings.

Key Findings:
  • The EORTC PATSAT-C33 and OUT-PATSAT7 demonstrated strong psychometric properties (e.g., reliability and validity) across diverse cultural contexts.
  • Patient satisfaction is significantly linked to treatment adherence and clinical outcomes in cancer care.
  • The study confirmed the questionnaires' applicability in both inpatient and outpatient settings.
Interpretation:

The validated questionnaires provide reliable tools for measuring patient satisfaction in cancer care, facilitating improvements in service delivery and patient-centered care, with implications for future research.

Limitations:
  • Potential biases in self-reported data may affect the accuracy of satisfaction assessments.
  • Limited generalizability due to specific cultural contexts of participating countries.
Conclusion:

The EORTC PATSAT-C33 and OUT-PATSAT7 are effective instruments for assessing patient satisfaction in oncology, supporting the need for continuous improvement in cancer care services to enhance patient outcomes.

Original Source(s)

International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies

  • by Anne Brédart, Jean-Luc Kop, Omar Shamieh, Louis Fox, Waleed Alrjoub, Thierry Conroy, Nazim Serdar Turhal, I. Juan Arraras, Renée Bultijnck, Amélie Harle, Mieke Van Hemelrijck, Eleonora Pinto, Eric J. U. Roth, Georgios Ioannidis, Anna Costantini, Tara Chalk, Teresa Young, Gudrun Rohde, Hiroto Ishiki, Yuichiro Kikawa, Heike Schmidt, Vassilios Vassiliou, Stephanie Shayler, Frédéric Marchal, Anota Amélie, Jens Lehmann

  • November 26, 2025

Related Content

The evolution of the posterior approach in hip surgery: Back to Langenbeck

Distinguishing Benign from Malignant Orbital Tumors through Deep Learning and Traditional Radiomics Analysis of CT Imaging

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms